Dr Helen Roberts 's Avatar

Dr Helen Roberts

@drhelenroberts.bsky.social

Associate Professor in Skeletal Cancer Research, Co-Director of the Centre for Investigative and Diagnostic Oncology, Director of Programmes at Middlesex University

77 Followers  |  157 Following  |  1 Posts  |  Joined: 24.02.2025  |  1.4192

Latest posts by drhelenroberts.bsky.social on Bluesky

What a beautiful image! Congratulations @drsjroberts.bsky.social!

29.08.2025 07:29 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
A graphic showing medicine acting against a cancer cell, with the Bone Cancer Research Trust logo in the bottom left corner and the CCLG logo in the bottom right corner.

A graphic showing medicine acting against a cancer cell, with the Bone Cancer Research Trust logo in the bottom left corner and the CCLG logo in the bottom right corner.

New research!

We're proud to be funding a study with @cclguk.bsky.social which could uncover new treatments for osteosarcoma πŸ”¬

Led by Prof Plevin @unistrathclyde.bsky.social, the team will investigate a protein called IKKΞ± and whether blocking it could stop cell growth.

Visit: ow.ly/WnwT50VGhfj

25.04.2025 10:03 β€” πŸ‘ 9    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

πŸ“‹ Importance: LGK974 therapy would likely be an option for treating disease early in children. This would potentially avoid risky surgical treatments such as skull decompression surgery.

22.04.2025 17:21 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

πŸ’‘A huge shout out to all of the authors of this study Tim Dreyer, Jacob Keen, Leah Wells, Mark Hopkinson, Isabel Orriss, Gill Holdsworth and Andy Pitsillides - you are all great! Also many thanks to our funders UCB Pharma for your continued support.

22.04.2025 17:21 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

πŸ’Š What We Found: A drug called LGK974 reduced skull and ear bone mass of young mice with sclerosteosis disease, indicating that it effectively limits skeletal overgrowth at sites with severe/fatal pathology.

22.04.2025 17:20 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 2    πŸ“Œ 0
Preview
Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies - Bone Research Bone Research - Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies

πŸ“’ New Publication: I am delighted to share our most recent paper, published in @natureportfolio.nature.com Journal Bone Research "Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies".

www.nature.com/articles/s41...

22.04.2025 17:18 β€” πŸ‘ 7    πŸ” 6    πŸ’¬ 1    πŸ“Œ 0

@drhelenroberts is following 19 prominent accounts